Abstract View

Author(s): Bhagyashri A Patil1, Ankita P Chaudhari2, Sandip A Tadavi3, Dr. Sunil P Pawar.4

Email(s): 1bhagyashripatil3888@gmail.com

Address:

    Department of Pharmaceutics P.S.G.V.P.M’s College of Pharmacy, Shahada

Published In:   Volume - 2,      Issue - 2,     Year - 2023

DOI: Not Available

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
Infectious disease management and vaccination practices have been revolutionized in recent years. With the development of biotechnology and genetic engineering, not only have many biological agents for certain diseases been produced, but also emphasis has been placed on the effective delivery of these biological agents. An alternative to liposomes, niosomes are vesicles made of biodegradable non-ionic surfactants, which are more harmless, more stable and less expensive. This article explores the current growth and expansion of interest in niosomes in various scientific fields, with an emphasis on their application in medicine. This article also provides a general overview of preparation methods, types and characterization and applications of niosomal gel. To combat various diseases, various pharmacological substances can be administered using niosomal. It could also be used to build new drug delivery systems for poorly absorbed drugs. It increases bioavailability by overcoming anatomical barriers of the digestive system through the transcytosis of Peyer's patch M cells into intestinal lymphoid tissues.

Cite this article:
Bhagyashri A Patil , Ankita P Chaudhari, Sandip A Tadavi , Dr. Sunil P Pawar. A Brief Review on Niosomal Gel. IJRPAS, 2023; 2(2):70-77.


1.   Mohd.Gayoor Khan. “The novel drug delivery system”, World journal of pharmacy and pharmaceutical sciences, Vol-6, Issue 7,477-487 ISSN 2278-4357.

2.   https:/www.sciencedirect.com/science/article/pii/B9780081025482000019.

3.   Vrunal V. More, Ritu M. Gilhotra, Manoj M. Nitalikar, Prajakta K. Khule , “Niosomal drug delivery” Asian journal of pharmaceutics, Oct-Dec 2018 (suppl) 12(4)|S1159].

4.   Mohamed Shafik E1-Ridy, Soad Aly Yehia, Amira Mohamed Mohsen, Sally A E1-Awdan and AsmaaBadawyDarwish. “Formulation of niosomla gel foe enhanced transdermal Lornoxicam delivery: In-vitro and In-vivo evaluation”, Current drug delivery,2018,15,122-133

5.   Varsha B. Patil, Sandip A. Tadvi, Sunil P. Pawar."Formulation of Niosomal Gel of Aceclofenac and it's In-vitro Characterization " Asian Journal of Drugs,2017, 5/(2) 78-87.

6.   AartiHardia, DarshanJamindar, Amisha Mahajan, AashishHardia“ Formuation and In vitro and skin permeability evaluation of Dexamethasone loaded Niosomal gel” ,Asian journal of pharmaceutical research and development, Vol5(2)March-April.2017:1-09.

7.   Moghassemi S, Hadjizadeh A (July 2014). "Nano-niosomes as nanoscale drug delivery systems: an illustrated review". Journal of Controlled Release. 185: 22–36. doi:10.1016/j.jconrel.2014.04.015. PMID 24747765.

8.   Buckton G., Harwood, Interfacial phenomena in Drug Delivery and Targeting Academic Publishers, Switzerland. 1995; p.154-155.

9.   Khan A, Sharma PK, Visht S, Malviya R. Niosomes as colloidal drug delivery system: a review. Journal of Chronotherapy and Drug Delivery. 2011;2:15–21.

10.    Gayatri Devi S, Venkatesh P, Udupa N. Niosomal sumatriptan succinate for nasal administration. Int J Pharm Sci 2000;62:479-81.

11.    Baillie A.J., Coombs G.H. and Dolan T.F. Non-ionic surfactant vesicles, niosomes, as delivery system for the anti-leishmanial drug, sodium stribogluconate  J.Pharm.Pharmacol. 1986; 38: 502-505.

12.    Raja Naresh R.A., Chandrashekhar G., Pillai G.K. and Udupa N. Antiinflammatory activity of Niosome encapsulated diclofenac sodium with Tween -85 in Arthitic rats. Ind.J.Pharmacol. 1994; 26:46-48.

13.    Maver L.D. Bally M.B. Hope. M.J. Cullis P.R. Biochem Biophys. Acta (1985), 816:294-302.

14.    Chauhan S. and Luorence M.J. The preparation of polyoxyethylene containing non-ionic surfactant. vesicles. J. Pharm. Pharmacol. 1989; 41: 6p.

15.    Blazek-Walsh A.I. and Rhodes D.G. Pharm. Res. SEM imaging predicts quality of niosomes from maltodextrin-based proniosomes. 2001; 18: 656-661.

16.    Baillie AJ, Coombs GH, Dolan TF, Laurie J. Non-ionic surfactant vesicles, niosomes, as delivery system for the anti-leishmanial drug, sodium stibogluconate. J Pharm Pharmacol. 1986;38:502–5.

17.    Khandare JN, Madhavi G, Tamhankar BM. Niosomes novel drug delivery system. East Pharmacist. 1994;37:61–4.

18.    Jayaraman SC, Ramachandran C, Weiner N. Topical delivery of erythromycin from various formulations: An in vivo hairless mouse study. J Pharm Sci. 1996;85:1082–4.

19.    Pardakhty A, Varshosaz J, Rouholamini A. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm. 2007;328:130–41.

20.     Y, Zhao F, Li N, Yang Y, Li K. Studies on a high encapsulation of colchicines by a noisome system. Int J Pharm. 2002;244:73–80.

21.    Uchegbu IF, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm. 1998;172:33–70.

22.    S. Moghassemi and A. Hadjizadeh, “Nano-niosomes as nanoscale drug delivery systems: an illustrated review,” Journal of Controlled Release, vol. 185, no. 1, pp. 22–36, 2014.

23.    Moghassemi S, Hadjizadeh A (July 2014). "Nano-niosomes as nanoscale drug delivery systems: an illustrated review". Journal of Controlled Release. 185: 22–36.

24.    Puras G, Mashal M, Zárate J, Agirre M, Ojeda E, Grijalvo S, Eritja R, Diaz-Tahoces A, Martínez Navarrete G, Avilés-Trigueros M, Fernández E, Pedraz JL (January 2014). "A novel cationic niosome formulation for gene delivery to the retina". Journal of Controlled Release. 174: 27–36.

25.    Aggarwal G, Goel A, Dhawan S, Shama A (2010). "Carriers/vesicles based approaches for penetration enhancement in transdermal drug delivery (1 - 5).

 


Related Images:



Recent Images



Neurological Complications among Pregnant and Post Partum Mothers in a Private Hospital, Yogyakarta, Indonesia
Review on Regulatory Affairs in Pharmaceutical Industry
Cucumber and Mint Soap: Preparation and Evaluation
Topical Delivery in Cosmetics: Enhancing Penetration and Bioavailability
Formulation and Evaluation of Polyherbal Soap
Gelatin: A Widely Used Pharmaceutical Excipient
Therapeutic insights into Saroglitazar: a dual PPAR- α/γ agonist targeting diabetic dyslipidaemia and NAFLD
A Comprehensive Review on Dyslipidemia and Obesity: Pathophysiology, Clinical Implications and Management Approaches
Antidiabetic Herbs and Polyherbal Antidiabetic Formulations –An Overview
Review on Clinical Research and Clinical Trials

Tags